Bundesrat,
Gesetz,
Kraft,
Direktor,
Entscheidung,
Meilenstein,
Menschen,
Zugang,
Medizin,
Hanf,
Pflanze,
Markt,
Erfolg,
Unternehmensgruppe,
Randbedingung,
Kommerzialisierung,
Standort,
Schritt,
Bundesministerium,
Gesundheit,
Phase,
Lieferkette,
Art Themen,
Handel,
Vertrieb,
Verpackung,
Werbung,
Interesse,
Verbraucher,
Wirtschaft,
Entwicklung,
Anleger (Finanzmarkt),
Community,
Wachstum,
Innovation,
Chief,
Officer,
Buy,
Gruppe,
Anbau,
Produktion,
Feld,
Regal,
Unternehmen,
Forschung,
Vermarktung,
CBD,
Strategie,
Expansion
Beschluss,
Deutscher Bundestag,
Freigabe,
Hanf,
Schritt,
Ausrichtung,
Unternehmensgruppe,
Chance,
Portfolio,
Akzeptanz,
Resonanz,
Anleger (Finanzmarkt),
Direktor,
Interesse,
Gesellschaft,
Woche,
Kurs,
Relevanz,
Anstrengung,
CEO,
Verwaltungsrat,
Wandelanleihe,
Bezugsrecht,
Markt,
Quartal,
Krise,
Nachfrage,
Bedeutung,
Unternehmenswachstum,
Fortschritt,
Therapie,
Forschung,
Bereich,
Aktie,
Zeichen,
Vertrauen,
Wachstum,
Innovation,
Erwartung,
Zukunftsmarkt,
Buy,
Unternehmen,
Entwicklung,
Produktion,
Vermarktung,
CBD,
Strategie,
Expansion
Retrieved on:
Samstag, Dezember 30, 2023
Quartal,
Anstieg,
Nachfrage,
Tochtergesellschaft,
Erholung,
Lieferkette,
Lage,
Bereich,
Wellness,
Lebensmittel,
Hanf,
Legalisierung,
Management,
Wechsel,
Kapitel,
Hand,
Direktor,
Unternehmen,
Erweiterung,
Verantwortung,
Integration,
Rahmen,
Buy,
CCO,
Chief,
Officer,
Marktteilnehmer,
Distributionspolitik,
Anforderung,
Portfolio,
Produkt,
Potential,
Distribution,
Markt,
The European,
Industrial,
Hemp,
Association,
EIHA,
Fokus,
Nutzhanf,
CEO,
Ziel,
Position,
Akteur,
Marktsegment,
Kunden,
Spektrum,
Unternehmensgruppe,
Build,
Strategie (Wirtschaft),
Forschung,
Entwicklung,
Produktion,
Vermarktung,
CBD,
Strategie,
Expansion
Retrieved on:
Dienstag, August 22, 2023
European Industrial Hemp Association,
MH,
Gesellschaft mit beschränkter Haftung,
Kruse,
Hemp,
VIVA,
Federation,
Acquisition,
EIHA,
CBD,
Cannabis,
SE,
Multi,
Synbiotics,
Management,
Security (finance),
Drug Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO
Key Points:
- Multi-entrepreneur Frank Otto invests in SynBiotic SE: The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO
The issuer is solely responsible for the content of this announcement.
- Multi-entrepreneur Frank Otto invests in SynBiotic SE:
Hemp pioneer Daniel Kruse joins SynBiotic management as CEO.
- As part of the acquisition, investor and CannaCare shareholder Frank Otto invests three million euros in SynBiotic SE through an extensive share package.
- Frank Otto on his investment: "For me, SynBiotic SE is the future of the European cannabis industry.
Retrieved on:
Dienstag, August 22, 2023
Retrieved on:
Sonntag, November 27, 2022
Retrieved on:
Sonntag, November 27, 2022
Marketing,
Union,
TSX,
Advisory board,
Pain,
ASX,
SE,
Sleep deprivation,
Anxiety,
NYSE,
Canopy Growth,
Research,
CSE,
News,
Synbiotics,
CAD,
Security (finance),
Drug SynBiotic SE, (SBX.DE) one of Germanys leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cannabis by securing Bruce Linton to its team.
Key Points:
- SynBiotic SE, (SBX.DE) one of Germanys leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cannabis by securing Bruce Linton to its team.
- Canopy was the first North American supplier to the German medical cannabis market.
- Mr. Linton has been appointed as Chairman of SynBiotics newly created Advisory Board and has invested capital in the companys most recent financing round.
- Lars Mller, CEO of SynBiotic SE, states: The fact that we are working with Bruce Linton is a true accolade.